Literature DB >> 23437998

Treatment adherence in cognitive processing therapy for combat-related PTSD with history of mild TBI.

Jeremy J Davis1, Kristen H Walter2, Kathleen M Chard2, R Bruce Parkinson1, Wes S Houston1.   

Abstract

OBJECTIVE: This retrospective study examined treatment adherence in Cognitive Processing Therapy (CPT) for combat-related posttraumatic stress disorder (PTSD) in Veterans of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) with and without history of mild traumatic brain injury (mTBI).
METHOD: Medical record review of consecutive referrals to an outpatient PTSD clinic identified veterans diagnosed with combat-related PTSD who began treatment with CPT. The sample (N = 136) was grouped according to positive (n = 44) and negative (n = 92) mTBI history. Groups were compared in terms of presenting symptoms and treatment adherence.
RESULTS: The groups were not different on a pretreatment measure of depression, but self-reported and clinician-rated PTSD symptoms were higher in veterans with history of mTBI. The treatment completion rate was greater than 61% in both groups. The number of sessions attended averaged 9.6 for the PTSD group and 7.9 for the mTBI/PTSD group (p = .05). IMPLICATIONS: Given the lack of marked group differences in treatment adherence, these initial findings suggest that standard CPT for PTSD may be a tolerable treatment for OEF/OIF veterans with a history of PTSD and mTBI as well as veterans with PTSD alone.

Entities:  

Mesh:

Year:  2013        PMID: 23437998     DOI: 10.1037/a0031525

Source DB:  PubMed          Journal:  Rehabil Psychol        ISSN: 0090-5550


  12 in total

1.  The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans.

Authors:  Daniel F Gros; Cynthia L Lancaster; Michael David Horner; Derek D Szafranski; Sudie E Back
Journal:  Compr Psychiatry       Date:  2017-07-17       Impact factor: 3.735

2.  VA residential treatment providers' use of two evidence-based psychotherapies for PTSD: Global endorsement versus specific components.

Authors:  Richard Thompson; Vanessa Simiola; Paula P Schnurr; Shannon Wiltsey Stirman; Joan M Cook
Journal:  Psychol Trauma       Date:  2016-11-28

Review 3.  An Overview of the Use of Neurofeedback Biofeedback for the Treatment of Symptoms of Traumatic Brain Injury in Military and Civilian Populations.

Authors:  Sarah N Gray
Journal:  Med Acupunct       Date:  2017-08-01

4.  Do early responders and treatment non-responders offer guidance to make CPT group a more effective treatment?

Authors:  M Wright Williams; Brooks King-Casas; Pearl H Chiu; Nicole Sciarrino; Matthew Estey; Christopher Hunt; Katherine McCurry; David P Graham
Journal:  J Clin Psychol       Date:  2022-02-16

5.  Cultural adaptations of prolonged exposure therapy for treatment and prevention of posttraumatic stress disorder in african americans.

Authors:  Monnica T Williams; Emily Malcoun; Broderick A Sawyer; Darlene M Davis; Leyla Bahojb Nouri; Simone Leavell Bruce
Journal:  Behav Sci (Basel)       Date:  2014-05-14

6.  A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.

Authors:  Brian Shiner; Christine Leonard Westgate; Jiang Gui; Shira Maguen; Yinong Young-Xu; Paula P Schnurr; Bradley V Watts
Journal:  J Clin Psychiatry       Date:  2018-09-18       Impact factor: 5.906

7.  Deployment-related mental health support: comparative analysis of NATO and allied ISAF partners.

Authors:  Eric Vermetten; Neil Greenberg; Manon A Boeschoten; Roos Delahaije; Rakesh Jetly; Carl A Castro; Alexander C McFarlane
Journal:  Eur J Psychotraumatol       Date:  2014-08-14

8.  White Matter Changes in Posttraumatic Stress Disorder Following Mild Traumatic Brain Injury: A Prospective Longitudinal Diffusion Tensor Imaging Study.

Authors:  Li Li; Gang Sun; Kai Liu; Min Li; Bo Li; Shao-Wen Qian; Li-Li Yu
Journal:  Chin Med J (Engl)       Date:  2016-05-05       Impact factor: 2.628

9.  Delivery of mental health treatment to combat veterans with psychiatric diagnoses and TBI histories.

Authors:  Shannon R Miles; Juliette M Harik; Natalie E Hundt; Joseph Mignogna; Nicholas J Pastorek; Karin E Thompson; Jessica S Freshour; Hong J Yu; Jeffrey A Cully
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

10.  Hemostatic nanoparticles increase survival, mitigate neuropathology and alleviate anxiety in a rodent blast trauma model.

Authors:  W Brad Hubbard; Margaret Lashof-Sullivan; Shaylen Greenberg; Carly Norris; Joseph Eck; Erin Lavik; Pamela VandeVord
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.